Sole Health Launches Angio Dynamics Long Wavelength 1470nm VenaCure Laser for EVLT.

Sole Health Care will launch the AngioDynamics low wavelength 1470nm Laser to Vascular and General  Surgeons, Phlebologists & Interventional Radiologists at the Australasian College of Phlebology meeting in Melbourne from 28th March - 2nd April.  Low wavelength lasers have been shown to minimise the risk of Brusing, Pain and Parasthesia (numbness) from Laser ablation because of the low energy output and slow delivery. Combined with the patented "nevertouch" fiber the Venacure system is the most Clinician and Patient friendly Laser on the Australian market.

 Sole Health Care signes 3 year Management Services Contracts  with US & European Device Manufacturers.

Sole Health Care have signed  Management Service Agreements to provide infrastructure support for  European  & American manufacturers  looking to market their companies products direct to the Australian & New Zealand Markets.  Under these 3 - 5 year agreements, Sole Health Care provides Regulatory, Distribution and Administrative support for the company’s products  whilst the company provides its own Sales and Sales Management team to promote the products in these markets. In this way non domestic manufacturers maintain control of the Customer base and margins whilst eliminating hassles and significant start up costs associated with administrative infrastructure, physical distribution,  billing and regulatory affairs.   Enquiries  for this service should be directed to Managing Director, Paul Nielsen at pnielsen@solehealth.com.au

 ------------------------------------------------------